
Interphex Tokyo 2025
INTERPHEX Week Tokyo is Asia’s premier B2B event for the pharmaceutical and biotechnology industries. The exhibition will feature five specialized shows, including INTERPHEX JAPAN, in-PHARMA JAPAN, BioPharma Expo, PharmaLab Tokyo, and the newly introduced PharmaDigital Transformation Expo, offering a comprehensive platform for industry professionals to explore cutting-edge technologies and innovations.
Date: July 9-11, 2025
Location: Tokyo Big Sight, Japan
Booth #: West Hall, 4F – W2-34
JOIN US!
Meet the Catalent team to explore our end-to-end CDMO solutions for oral small molecules, consumer health, and biologics. From development to clinical supply and commercial manufacturing, our global expertise and integrated capabilities can accelerate your path to market. Schedule a meeting today!
SPEAKING ENGAGEMENTS
Clinical Supply Solutions
Brent Winslow, Director, Operations
Thursday, July 10 | 10:50 –11:20 AM
Beyond Misconceptions: How Lipid-Based Formulations Accelerate BCS II & IV Drug Development
Karunakar Sukuru, Global VP, Pharma Product Development
Friday, July 11 | 2:10-2:40 PM
NETWORKING RECEPTION
Date: July 10, 2025
Time: 6:00 – 8:00 PM
Location: Tokyo Bay Ariake Washington Hotel
Register Here
Join Catalent for an exclusive networking reception during Interphex—an evening designed for industry innovators and partners to connect over dinner, drinks, and engaging discussion. Hear from experts on the global trends shaping the Japanese pharma market and how Catalent continues to adapt to these shifts to deliver better treatments to patients worldwide.
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.